Hanne Marte Nymoen is a medical doctor with a background primarily in oncology and internal medicine. She is currently pursuing a PhD as part of the DART study, with her primary research focus centered on the role of the gut microbiota and its associations with cancer therapies, including immunotherapy, in patients with lung cancer.